Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.

INTRODUCTION: The Lambert Eaton myasthenic syndrome (LEMS) is a paraneoplastic disorder associated with raised serum voltage-gated calcium channel (VGCC) antibodies in patients with small cell lung cancer (SCLC). VGCC can also be found in patients with SCLC and cerebellar ataxia. This was a prospec...

Descripció completa

Dades bibliogràfiques
Autors principals:	Payne, M, Bradbury, P, Lang, B, Vincent, A, Han, C, Newsom-Davis, J, Talbot, D
Format:	Journal article
Idioma:	English
Publicat:	2010

Ítems similars

Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
per: Lang, B, et al.
Publicat: (2003)

A prospective study of the incidence of sub-clinical Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer (SCLC)
per: Bradbury, P, et al.
Publicat: (2004)

A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).
per: Bradbury, P, et al.
Publicat: (2004)

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
per: Maddison, P, et al.
Publicat: (2001)

Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma
per: Lang, B, et al.
Publicat: (2008)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
per: Squier, M, et al.
Publicat: (1991)

The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma
per: Briggs SEW, et al.
Publicat: (2013-05-01)

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
per: Titulaer, M, et al.
Publicat: (2010)

Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
per: Sumera Bukhari MD, et al.
Publicat: (2017-07-01)

Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article
per: Paulo José Lorenzoni, et al.

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
per: Wirtz, P, et al.
Publicat: (2003)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report
per: Cruz, M, et al.
Publicat: (2005)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
per: Palace, J, et al.
Publicat: (2004)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
per: Motomura, M, et al.
Publicat: (1997)

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
per: Bain, P, et al.
Publicat: (1996)

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
per: Pinto, A, et al.
Publicat: (2002)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
per: Lorenzoni, P, et al.
Publicat: (2008)

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
per: Yutaka Furukawa, et al.
Publicat: (2022-09-01)

062 Pembrolizumab induced lambert-eaton myasthenic syndrome
per: Rob Zielinski, et al.
Publicat: (2021-08-01)

Lambert Eaton myasthenic syndrome and pregnancies with the development of transient myasthenic syndrome in newborn
per: N. I. Shcherbakova, et al.
Publicat: (2015-02-01)

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
per: Titulaer, M, et al.
Publicat: (2011)

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
per: Wirtz, P, et al.
Publicat: (2005)

Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome
per: Naoya Ishibashi, et al.
Publicat: (2024-01-01)

Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
per: Lang, B
Publicat: (2007)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
per: Maddison, P, et al.
Publicat: (2011)

Pseudomyopathic Changes in Needle Electromyography in Lambert-Eaton Myasthenic Syndrome
per: Teppei Komatsu, et al.
Publicat: (2013-01-01)

Electrophysiological and muscle pathological characteristics of Lambert - Eaton myasthenic syndrome
per: SUN Qing, et al.
Publicat: (2024-10-01)

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
per: Lang, B, et al.
Publicat: (2013)

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer
per: Kavita Agrawal, et al.
Publicat: (2019-01-01)

Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report
per: Michimi Otani, MD, et al.
Publicat: (2023-11-01)

Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
per: Lehnerer, S, et al.
Publicat: (2024)

Electron microscopic study of skeletal muscle in the Lambert–Eaton myasthenic syndrome
per: L. L. Babakova, et al.
Publicat: (2015-02-01)

Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
per: Simister, R, et al.
Publicat: (2011)

P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
per: Wirtz, P, et al.
Publicat: (2005)

Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
per: Yuki Nakatani, et al.
Publicat: (2018-12-01)

Atypical Presentation of Seronegative Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Ataxia
per: Shalesh Rohatgi, et al.
Publicat: (2024-06-01)

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
per: Pascuzzi RM, et al.
Publicat: (2022-12-01)

SOX‐1 antibodies positive Lambert–Eaton myasthenic syndrome with occult small cell lung cancer: A case report
per: Liming Zhao, et al.
Publicat: (2024-03-01)

Adenocarcinoma pulmonar, dermatomiosite e síndrome miastênica de Lambert-Eaton: uma rara associação Lung adenocarcinoma, dermatomyositis, and Lambert-Eaton myasthenic syndrome: a rare combination
per: Fernanda Manente Milanez, et al.
Publicat: (2008-05-01)

Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
per: Rozsa, C, et al.
Publicat: (2008)